Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Iggo

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
Targeted radionuclide therapy using a Wnt-targeted replicating adenovirus encoding the Na/I symporterInge Peerlinck, Andrew Merron, Patrick Baril, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 21, 2019
Solid-type adenoid cystic carcinoma of the breast, a distinct molecular entity enriched in NOTCH and CREBBP mutationsJulie Massé, Caroline Truntzer, Romain Boidot, et al.
Plos One|January 4, 2013
Deletion of chromosomes 13q and 14q is a common feature of tumors with BRCA2 mutationsAudrey Rouault, Guillaume Banneau, Gaëtan Macgrogan, et al.
Oncogene|May 18, 2005
Identification of molecular apocrine breast tumours by microarray analysisPierre Farmer, Herve Bonnefoi, Veronique Becette, et al.
Journal of Mammary Gland Biology and Neoplasia|July 14, 2023
Imagine beyond: recent breakthroughs and next challenges in mammary gland biology and breast cancer researchRenée van Amerongen, Mohamed Bentires-Alj, Antonius L van Boxtel, et al.
Oncogene|November 24, 2023
Selective inhibition of CDK9 in triple negative breast cancerEbtihal H Mustafa, Geraldine Laven-Law, Zoya Kikhtyak, et al.
Stem Cell Reports|January 21, 2015
Disequilibrium of BMP2 levels in the breast stem cell niche launches epithelial transformation by overamplifying BMPR1B cell responseMarion Chapellier, Elodie Bachelard-Cascales, Xenia Schmidt, et al.
British Journal of Cancer|March 23, 2019
Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomesHervé Bonnefoi, Gaetan MacGrogan, Coralie Poncet, et al.
Breast Cancer Research : BCR|August 18, 2010
Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutationsGuillaume Banneau, Mickaël Guedj, Gaëtan MacGrogan, et al.
Nature Medicine|January 6, 2009
A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancerPierre Farmer, Hervé Bonnefoi, Pascale Anderle, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
Targeted radionuclide therapy using a Wnt-targeted replicating adenovirus encoding the Na/I symporterInge Peerlinck, Andrew Merron, Patrick Baril, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 21, 2019
Solid-type adenoid cystic carcinoma of the breast, a distinct molecular entity enriched in NOTCH and CREBBP mutationsJulie Massé, Caroline Truntzer, Romain Boidot, et al.
Plos One|January 4, 2013
Deletion of chromosomes 13q and 14q is a common feature of tumors with BRCA2 mutationsAudrey Rouault, Guillaume Banneau, Gaëtan Macgrogan, et al.
Oncogene|May 18, 2005
Identification of molecular apocrine breast tumours by microarray analysisPierre Farmer, Herve Bonnefoi, Veronique Becette, et al.
Journal of Mammary Gland Biology and Neoplasia|July 14, 2023
Imagine beyond: recent breakthroughs and next challenges in mammary gland biology and breast cancer researchRenée van Amerongen, Mohamed Bentires-Alj, Antonius L van Boxtel, et al.
Oncogene|November 24, 2023
Selective inhibition of CDK9 in triple negative breast cancerEbtihal H Mustafa, Geraldine Laven-Law, Zoya Kikhtyak, et al.
Stem Cell Reports|January 21, 2015
Disequilibrium of BMP2 levels in the breast stem cell niche launches epithelial transformation by overamplifying BMPR1B cell responseMarion Chapellier, Elodie Bachelard-Cascales, Xenia Schmidt, et al.
British Journal of Cancer|March 23, 2019
Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomesHervé Bonnefoi, Gaetan MacGrogan, Coralie Poncet, et al.
Breast Cancer Research : BCR|August 18, 2010
Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutationsGuillaume Banneau, Mickaël Guedj, Gaëtan MacGrogan, et al.
Nature Medicine|January 6, 2009
A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancerPierre Farmer, Hervé Bonnefoi, Pascale Anderle, et al.
Pageof 5